Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001307339 | SCV001496746 | likely benign | Cowden syndrome | 2023-08-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002430117 | SCV002743219 | likely benign | Inborn genetic diseases | 2022-04-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004692460 | SCV005189897 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004545194 | SCV004776100 | likely benign | PIK3CA-related disorder | 2020-03-02 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |